Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20082
20093
20105
20111
20141
20151
20161
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
AstraZeneca2
Eli Lilly and Company2
GlaxoSmithKline2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Bristol-Myers Squibb1
CSL Behring1
DalCor Pharmaceuticals1
J.M. ten Berg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome19
Cardiovascular Diseases5
Heart Diseases5
Coronary Artery Disease4
Myocardial Infarction4
Angina, Unstable3
Angina, Stable2
Atherosclerosis2
Coronary Disease2
Myocardial Ischemia2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.